Helix Biotech is a customer and quality-focused Contract Development and Manufacturing Organisation (CDMO) specialising in lipid nanoparticles (LNPs), liposomes, and hybrid nanoparticles. The company is dedicated to providing cost-effective, high-yield encapsulation solutions, utilising cutting-edge equipment and reagents. With a team that has years of proven expertise in formulation, analytical testing, and developing manufacturing systems for nanoparticle drug delivery, Helix Biotech offers a comprehensive range of services from proof-of-concept to GMP manufacturing, ensuring the success of every project.

Services include:

- Lipid nanoparticle formulation
- Liposome production
- Emulsion manufacturing
- Polymer synthesis
- Dendrimer development
- Analytical testing services
- GMP manufacturing
- Customised service packages

Helix Biotech is committed to delivering end-to-end solutions tailored to projects ranging from research-use-only to GMP, reinforcing its role as a key partner in the pharmaceutical industry. For more information, please visit helixbiotech.com.